LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday. The company traded as low as $75.61 and last traded at $76.3690, with a volume of 3,366 shares trading hands. The stock had previously closed at $77.01.
Wall Street Analyst Weigh In
LMAT has been the subject of several analyst reports. Wells Fargo & Company lowered their target price on LeMaitre Vascular from $94.00 to $86.00 and set an “equal weight” rating for the company in a research note on Thursday, November 5th. Seaport Research Partners set a $110.00 price objective on LeMaitre Vascular in a research note on Thursday, November 5th. Weiss Ratings cut LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 23rd. Barrington Research downgraded LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 5th. Finally, Wall Street Zen lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Three investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, LeMaitre Vascular presently has an average rating of “Hold” and a consensus price target of $108.25.
Check Out Our Latest Report on LeMaitre Vascular
LeMaitre Vascular Price Performance
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The medical instruments supplier reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $67.97 million for the quarter, compared to analyst estimates of $67.39 million. LeMaitre Vascular had a return on equity of 15.33% and a net margin of 23.51%. The firm’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.75 EPS. On average, equities research analysts predict that LeMaitre Vascular, Inc. will post 2.83 EPS for the current fiscal year.
LeMaitre Vascular Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 3rd. Investors of record on Thursday, November 19th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 1.3%. The ex-dividend date is Thursday, November 19th. LeMaitre Vascular’s dividend payout ratio (DPR) is currently 36.36%.
Institutional Investors Weigh In On LeMaitre Vascular
A number of institutional investors and hedge funds have recently bought and sold shares of LMAT. Sterling Capital Management LLC grew its holdings in shares of LeMaitre Vascular by 844.2% during the third quarter. Sterling Capital Management LLC now owns 727 shares of the medical instruments supplier’s stock worth $60,000 after purchasing an additional 650 shares during the last quarter. Nykredit A S purchased a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at about $82,000. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of LeMaitre Vascular in the 2nd quarter valued at about $102,000. EverSource Wealth Advisors LLC boosted its position in shares of LeMaitre Vascular by 28.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,393 shares of the medical instruments supplier’s stock valued at $152,000 after purchasing an additional 308 shares during the period. Finally, Teton Advisors LLC acquired a new stake in shares of LeMaitre Vascular in the 1st quarter valued at about $218,000. 84.64% of the stock is owned by hedge funds and other institutional investors.
About LeMaitre Vascular
LeMaitre Vascular develops, manufactures and markets medical devices used primarily in the treatment of vascular disease. Its products support procedures performed by vascular surgeons and include vascular grafts, embolectomy catheters, carotid shunts, valvulotomes and other instruments used in vascular surgery. Founded in 1983 by vascular surgeon George LeMaitre, the company is headquartered in Burlington, Massachusetts. Its products are sold to hospitals and medical professionals around the world through a combination of direct sales and distributors.
Read More
- Five stocks we like better than LeMaitre Vascular
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.
